Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus

• Published in: Diabetologia 2004-03, Vol.47 (3), p.549-554
• Main Authors: CHO, Y. M, RITCHIE, M. D, MOORE, J. H, PARK, J. Y, LEE, K.-U, SHIN, H. D, LEE, H. K, PARK, K. S
• Format: Article
• Language: English
• Subjects: Aged; Amino Acid Substitution; Biological and medical sciences; Chromosome Mapping; Diabetes; Diabetes Mellitus, Type 2 - genetics; Diabetes. Impaired glucose tolerance; Disease; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Fatty acids; Female; Genes; Genetic disorders; Genomes; Humans; Insulin; Internal medicine; Ion Channels; Male; Medical sciences; Medicine; Membrane Transport Proteins - genetics; Middle Aged; Mitochondrial Proteins - genetics; Models, Genetic; Polymorphism; Polymorphism, Genetic; PPAR gamma - genetics; Proteins; Uncoupling Protein 2
• ISSN: 0012-186X; 1432-0428
• DOI: 10.1007/s00125-003-1321-3

Type 2 diabetes mellitus is a complex genetic disease, which results from interactions between multiple genes and environmental factors without any single factor having strong independent effects. This study was done to identify gene to gene interactions which could be associated with the risk of Type 2 diabetes. We genotyped 23 different loci in the 15 candidate genes of Type 2 diabetes in 504 unrelated Type 2 diabetic patients and 133 non-diabetic control subjects. We analysed gene to gene interactions among 23 polymorphic loci using the multifactor-dimensionality reduction (MDR) method, which has been shown to be effective for detecting and characterising gene to gene interactions in case-control studies with relatively small samples. The MDR analysis showed a significant gene to gene interaction between the Ala55Val polymorphism in the uncoupling protein 2 gene ( UCP2) and the 161C>T polymorphism in the exon 6 of peroxisome proliferator-activated receptor gamma ( PPARgamma) gene. This interaction showed the maximum consistency and minimum prediction error among all gene to gene interaction models evaluated. Moreover, the combination of the UCP2 55 Ala/Val heterozygote and the PPARgamma 161 C/C homozygote was associated with a reduced risk of Type 2 diabetes (odds ratio: 0.51, 95% CI: 0.34 to 0.77, p=0.0016). Using the MDR method, we showed a two-locus interaction between the UCP2 and PPARgamma genes among 23 loci in the candidate genes of Type 2 diabetes. The determination of such genotype combinations contributing to Type 2 diabetes mellitus could provide a new tool for identifying high-risk individuals.